2020 Global Fingolimod Market Outlook

Publisher Name :
Date: 27-Dec-2019
No. of pages: 98
Inquire Before Buying

The global Fingolimod market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.

This report focuses on Fingolimod volume and value at global level, regional level and company level. From a global perspective, this report represents overall Fingolimod market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:

- Novartis

- AstraZeneca

- ...

Segment by Regions

- North America

- Europe

- China

- Japan

Segment by Type

- Oral

- Injection

Segment by Application

- Medical Field

- Science Research Field

- Other Field

2020 Global Fingolimod Market Outlook

Table of Contents
Executive Summary
1 Fingolimod Market Overview
1.1 Product Overview and Scope of Fingolimod
1.2 Fingolimod Segment by Type
1.2.1 Global Fingolimod Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Oral
1.2.3 Injection
1.3 Fingolimod Segment by Application
1.3.1 Fingolimod Consumption Comparison by Application (2014-2025)
1.3.2 Medical Field
1.3.3 Science Research Field
1.3.4 Other Field
1.4 Global Fingolimod Market by Region
1.4.1 Global Fingolimod Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Fingolimod Market Size
1.5.1 Global Fingolimod Revenue (2014-2025)
1.5.2 Global Fingolimod Production (2014-2025)
2 Global Fingolimod Market Competition by Manufacturers
2.1 Global Fingolimod Production Market Share by Manufacturers (2014-2019)
2.2 Global Fingolimod Revenue Share by Manufacturers (2014-2019)
2.3 Global Fingolimod Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Fingolimod Production Sites, Area Served, Product Types
2.5 Fingolimod Market Competitive Situation and Trends
2.5.1 Fingolimod Market Concentration Rate
2.5.2 Fingolimod Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Fingolimod Production Market Share by Regions
3.1 Global Fingolimod Production Market Share by Regions
3.2 Global Fingolimod Revenue Market Share by Regions (2014-2019)
3.3 Global Fingolimod Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Fingolimod Production
3.4.1 North America Fingolimod Production Growth Rate (2014-2019)
3.4.2 North America Fingolimod Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Fingolimod Production
3.5.1 Europe Fingolimod Production Growth Rate (2014-2019)
3.5.2 Europe Fingolimod Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Fingolimod Production
3.6.1 China Fingolimod Production Growth Rate (2014-2019)
3.6.2 China Fingolimod Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Fingolimod Production
3.7.1 Japan Fingolimod Production Growth Rate (2014-2019)
3.7.2 Japan Fingolimod Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Fingolimod Consumption by Regions
4.1 Global Fingolimod Consumption by Regions
4.2 North America Fingolimod Consumption (2014-2019)
4.3 Europe Fingolimod Consumption (2014-2019)
4.4 China Fingolimod Consumption (2014-2019)
4.5 Japan Fingolimod Consumption (2014-2019)
5 Global Fingolimod Production, Revenue, Price Trend by Type
5.1 Global Fingolimod Production Market Share by Type (2014-2019)
5.2 Global Fingolimod Revenue Market Share by Type (2014-2019)
5.3 Global Fingolimod Price by Type (2014-2019)
5.4 Global Fingolimod Production Growth by Type (2014-2019)
6 Global Fingolimod Market Analysis by Applications
6.1 Global Fingolimod Consumption Market Share by Application (2014-2019)
6.2 Global Fingolimod Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Fingolimod Business
7.1 Novartis
7.1.1 Novartis Fingolimod Production Sites and Area Served
7.1.2 Fingolimod Product Introduction, Application and Specification
7.1.3 Novartis Fingolimod Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 AstraZeneca
7.2.1 AstraZeneca Fingolimod Production Sites and Area Served
7.2.2 Fingolimod Product Introduction, Application and Specification
7.2.3 AstraZeneca Fingolimod Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
8 Fingolimod Manufacturing Cost Analysis
8.1 Fingolimod Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Fingolimod
8.4 Fingolimod Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Fingolimod Distributors List
9.3 Fingolimod Customers
10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors
11 Global Fingolimod Market Forecast
11.1 Global Fingolimod Production, Revenue Forecast
11.1.1 Global Fingolimod Production Growth Rate Forecast (2019-2025)
11.1.2 Global Fingolimod Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Fingolimod Price and Trend Forecast (2019-2025)
11.2 Global Fingolimod Production Forecast by Regions (2019-2025)
11.2.1 North America Fingolimod Production, Revenue Forecast (2019-2025)
11.2.2 Europe Fingolimod Production, Revenue Forecast (2019-2025)
11.2.3 China Fingolimod Production, Revenue Forecast (2019-2025)
11.2.4 Japan Fingolimod Production, Revenue Forecast (2019-2025)
11.3 Global Fingolimod Consumption Forecast by Regions (2019-2025)
11.3.1 North America Fingolimod Consumption Forecast (2019-2025)
11.3.2 Europe Fingolimod Consumption Forecast (2019-2025)
11.3.3 China Fingolimod Consumption Forecast (2019-2025)
11.3.4 Japan Fingolimod Consumption Forecast (2019-2025)
11.4 Global Fingolimod Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Fingolimod Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
List of Tables and Figures
Figure Picture of Fingolimod
Table Global Fingolimod Production (K MT) Growth Rate Comparison by Types (2014-2025)
Figure Global Fingolimod Production Market Share by Types in 2018
Figure Oral Product Picture
Table Oral Major Manufacturers
Figure Injection Product Picture
Table Injection Major Manufacturers
Table Global Fingolimod Consumption (K MT) Comparison by Applications (2014-2025)
Figure Global Fingolimod Consumption Market Share by Applications in 2018
Figure Medical Field
Figure Science Research Field
Figure Other Field
Table Fingolimod Market Size (Million US$) Comparison by Regions (2014-2025)
Figure North America Fingolimod Revenue (Million USD) and Growth Rate (2014-2025)
Figure Europe Fingolimod Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Fingolimod Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Fingolimod Revenue (Million USD) and Growth Rate (2014-2025)
Figure Global Fingolimod Revenue (Million USD) (2014-2025)
Figure Global Fingolimod Production (K MT) (2014-2025)
Table Global Fingolimod Production (K MT) of Key Manufacturers (2014-2019)
Table Global Fingolimod Production Share by Manufacturers (2014-2019)
Figure Fingolimod Production Share by Manufacturers in 2018
Table Global Fingolimod Revenue (Million USD) by Manufacturers (2014-2019)
Table Global Fingolimod Revenue Share by Manufacturers (2014-2019)
Figure Global Fingolimod Revenue Share by Manufacturers in 2018
Table Global Market Fingolimod Average Price (USD/MT) of Key Manufacturers (2014-2019)
Figure Global Market Fingolimod Average Price (USD/MT) of Key Manufacturers in 2018
Table Manufacturers Fingolimod Production Sites and Area Served
Table Manufacturers Fingolimod Product Types
Figure Fingolimod Market Share of Top 5 Manufacturers
Figure Fingolimod Market Share of Top 10 Manufacturers
Table Global Fingolimod Production (K MT) by Region (2014-2019)
Table Global Fingolimod Production Market Share by Region (2014-2019)
Figure Global Fingolimod Production Market Share by Region (2014-2019)
Figure Global Fingolimod Production Market Share by Region in 2018
Table Global Fingolimod Revenue (Million USD) by Region (2014-2019)
Table Global Fingolimod Revenue Market Share by Region (2014-2019)
Figure Global Fingolimod Revenue Market Share by Region (2014-2019)
Figure Global Fingolimod Revenue Market Share by Region in 2018
Figure Global Fingolimod Production (K MT) Growth Rate (2014-2019)
Table Global Fingolimod Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Figure North America Fingolimod Production (K MT) Growth Rate (2014-2019)
Table North America Fingolimod Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Figure Europe Fingolimod Production (K MT) Growth Rate (2014-2019)
Table Europe Fingolimod Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Figure China Fingolimod Production (K MT) Growth Rate (2014-2019)
Table China Fingolimod Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Figure Japan Fingolimod Production (K MT) Growth Rate (2014-2019)
Table Japan Fingolimod Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Global Fingolimod Consumption (K MT) Market by Region (2014-2019)
Table Global Fingolimod Consumption Market Share by Region (2014-2019)
Figure Global Fingolimod Consumption Market Share by Region (2014-2019)
Figure Global Fingolimod Consumption Market Share by Region in 2018
Figure North America Fingolimod Consumption Growth Rate (2014-2019) (K MT)
Figure Europe Fingolimod Consumption Growth Rate (2014-2019) (K MT)
Figure China Fingolimod Consumption Growth Rate (2014-2019) (K MT)
Figure Japan Fingolimod Consumption Growth Rate (2014-2019) (K MT)
Table Global Fingolimod Production (K MT) by Type (2014-2019)
Table Global Fingolimod Production Share by Type (2014-2019)
Figure Production Market Share of Fingolimod by Type (2014-2019)
Figure Production Market Share of Fingolimod by Type in 2018
Table Global Fingolimod Revenue (Million USD) by Type (2014-2019)
Table Global Fingolimod Revenue Share by Type (2014-2019)
Figure Revenue Share of Fingolimod by Type (2014-2019)
Figure Revenue Market Share of Fingolimod by Type in 2018
Table Global Fingolimod Price (USD/MT) by Type (2014-2019)
Figure Global Fingolimod Production Growth by Type (2014-2019) (K MT)
Table Global Fingolimod Consumption (K MT) by Application (2014-2019)
Table Global Fingolimod Consumption Market Share by Application (2014-2019)
Figure Global Fingolimod Consumption Market Share by Applications (2014-2019)
Figure Global Fingolimod Consumption Market Share by Application in 2018
Table Global Fingolimod Consumption Growth Rate by Application (2014-2019)
Figure Global Fingolimod Consumption Growth Rate by Application (2014-2019)
Table Novartis Fingolimod Production Sites and Area Served
Table Novartis Product Introduction, Application and Specification
Table Novartis Fingolimod Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Figure Novartis Fingolimod Production Growth Rate (2014-2019)
Figure Novartis Fingolimod Production Market Share (2014-2019)
Figure Novartis Fingolimod Revenue Market Share (2014-2019)
Table Novartis Main Business and Markets Served
Table AstraZeneca Fingolimod Production Sites and Area Served
Table AstraZeneca Product Introduction, Application and Specification
Table AstraZeneca Fingolimod Production (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Figure AstraZeneca Fingolimod Production Growth Rate (2014-2019)
Figure AstraZeneca Fingolimod Production Market Share (2014-2019)
Figure AstraZeneca Fingolimod Revenue Market Share (2014-2019)
Table AstraZeneca Main Business and Markets Served
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Fingolimod
Figure Manufacturing Process Analysis of Fingolimod
Figure Fingolimod Industrial Chain Analysis
Table Fingolimod Distributors List
Table Fingolimod Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Figure Global Fingolimod Production (K MT) and Growth Rate Forecast (2019-2025)
Figure Global Fingolimod Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Global Fingolimod Price and Trend Forecast (2019-2025)
Table Global Fingolimod Production (K MT) Forecast by Region (2019-2025)
Figure Global Fingolimod Production Market Share Forecast by Region (2019-2025)
Figure North America Fingolimod Production (K MT) and Growth Rate Forecast (2019-2025)
Figure North America Fingolimod Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Europe Fingolimod Production (K MT) and Growth Rate Forecast (2019-2025)
Figure Europe Fingolimod Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure China Fingolimod Production (K MT) and Growth Rate Forecast (2019-2025)
Figure China Fingolimod Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Japan Fingolimod Production (K MT) and Growth Rate Forecast (2019-2025)
Figure Japan Fingolimod Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Table Global Fingolimod Consumption (K MT) Forecast by Regions (2019-2025)
Figure Global Fingolimod Consumption Market Share Forecast by Regions (2019-2025)
Figure North America Fingolimod Consumption (K MT) Growth Rate Forecast (2019-2025)
Figure Europe Fingolimod Consumption (K MT) Growth Rate Forecast (2019-2025)
Figure China Fingolimod Consumption (K MT) Growth Rate Forecast (2019-2025)
Figure Japan Fingolimod Consumption (K MT) Growth Rate Forecast (2019-2025)
Table Global Fingolimod Production (K MT) Forecast by Type (2019-2025)
Figure Global Fingolimod Production (K MT) Forecast by Type (2019-2025)
Table Global Fingolimod Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Fingolimod Revenue Market Share Forecast by Type (2019-2025)
Table Global Fingolimod Price (USD/MT) Forecast by Type (2019-2025)
Table Global Fingolimod Consumption (K MT) Forecast by Application (2019-2025)
Figure Global Fingolimod Consumption Forecast by Application (2019-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Fingolimod Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Fingolimod market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Fingolimod is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Fingolimod is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Multiple Sclerosis Drugs Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The Multiple Sclerosis Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Multiple Sclerosis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provi......
  • Global Multiple Sclerosis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118
    Market Overview of Global Multiple Sclerosis market: According to our latest research, the global Multiple Sclerosis market looks promising in the next 5 years. As of 2022, the global Multiple Sclerosis market was estimated at USD 13809.22 million, and it's anticipated to reach USD 21672.55 million in 2028, with a CAGR of 7.8% during the forecast years. Multiple sclerosis (MS) is a chronic inflammatory neuropathy characterized by demyelination, axonal transection, and neurode......
  • Fingolimod - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 77
    The global Fingolimod market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Fingolimod in various end use industries. The expanding demands from the Medical Field, Science Research Field and Other Fields,, are propelling Fingolimod market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Inj......
  • Global Fingolimod Market Research Report 2023, Forecast to 2028
    Published: 19-Dec-2023        Price: US 2680 Onwards        Pages: 133
    Fingolimod, sold under the brand name Gilenya, is an immunomodulating medication, mostly used for treating multiple sclerosis (MS). Fingolimod is a sphingosine-1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) dat......
  • Global Fingolimod Professional Survey Report 2023, Forecast to 2028
    Published: 19-Dec-2023        Price: US 3280 Onwards        Pages: 101
    Fingolimod, sold under the brand name Gilenya, is an immunomodulating medication, mostly used for treating multiple sclerosis (MS). Fingolimod is a sphingosine-1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) dat......
  • Multiple Sclerosis Drugs - Global Market Insights and Sales Trends 2024
    Published: 19-Dec-2023        Price: US 3350 Onwards        Pages: 96
    This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Multiple Sclerosis Drugs, with both qu......
  • Global Multiple Sclerosis Drugs Market Research Report 2023
    Published: 25-Oct-2023        Price: US 2900 Onwards        Pages: 87
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Multiple Sclerosis Drugs market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Biogen - Sanofi - Novartis - Teva - Merck KGaA - Bayer - ACORDA - Mallinckrodt Segment by Type - Injectable......
  • Global Multiple Sclerosis Drugs Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 13-Jun-2023        Price: US 3260 Onwards        Pages: 122
    Multiple sclerosis (MS) is the most common disabling neurological disease in young people worldwide. The Multiple Sclerosis Drugs market revenue was 15099.44 Million USD in 2022, and will reach 23584.78 Million USD in 2028, with a CAGR of 7.72% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Multiple Sclerosis Drugs industry, and breaks down according to the type, application, and consumption area of Multiple Sclero......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs